ストックスクリーナーアプリを入手
8.37
0.36%
-0.03
前日終値:
$8.40
開ける：
$8.37
24時間の取引高:
2.30M
Relative Volume:
2.25
時価総額：
$625.09M
収益：
-
当期純損益:
$-27.03M
株価収益率:
-14.95
EPS:
-0.56
ネットキャッシュフロー:
$-23.97M
1週間 パフォーマンス:
-4.99%
1か月 パフォーマンス:
+2.32%
6か月 パフォーマンス:
+97.41%
1年 パフォーマンス:
+3.59%
1日の値動き範囲:
$8.26
$8.56
1週間の範囲:
$8.26
$9.60
52週間の値動き範囲:
$2.54
$9.60
Corvus Pharmaceuticals Inc Stock (CRVS) Company Profile
名前
Corvus Pharmaceuticals Inc
セクター
電話
(650) 900-4520
住所
863 MITTEN ROAD, BURLINGAME, CA
CRVS を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
CRVS
Corvus Pharmaceuticals Inc
|
8.37 | 627.33M | 0 | -27.03M | -23.97M | -0.56 |
|
VRTX
Vertex Pharmaceuticals Inc
|
452.04 | 113.14B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
741.29 | 78.49B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ARGX
Argen X Se Adr
|
877.94 | 54.76B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
397.55 | 54.51B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
INSM
Insmed Inc
|
197.01 | 41.64B | 447.02M | -1.18B | -906.14M | -6.1812 |
Corvus Pharmaceuticals Inc Stock (CRVS) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-10-13 | 開始されました | Barclays | Overweight |
| 2025-01-02 | 開始されました | H.C. Wainwright | Buy |
| 2023-08-18 | 開始されました | Oppenheimer | Outperform |
| 2021-12-01 | 再開されました | Jefferies | Buy |
| 2021-05-27 | 開始されました | Cantor Fitzgerald | Overweight |
| 2021-02-10 | ダウングレード | Mizuho | Buy → Neutral |
| 2019-09-12 | 開始されました | Mizuho | Buy |
| 2019-05-29 | 開始されました | ROTH Capital | Buy |
| 2017-08-24 | アップグレード | Credit Suisse | Underperform → Neutral |
| 2017-05-01 | ダウングレード | Credit Suisse | Neutral → Underperform |
| 2016-04-18 | 開始されました | Credit Suisse | Outperform |
| 2016-04-18 | 開始されました | Guggenheim | Buy |
すべてを表示
Corvus Pharmaceuticals Inc (CRVS) 最新ニュース
Corvus Pharmaceuticals stock awaits key January 2026 trial data By Investing.com - Investing.com Canada
Is Corvus Pharmaceuticals Inc a good long term investmentMarket Depth Overview & Budget Friendly Stock Tips - earlytimes.in
What is Corvus Pharmaceuticals Inc (CRVS) Stock Return on Shareholders’ Capital? - setenews.com
Corvus Pharmaceuticals (NASDAQ:CRVS) Trading 7.1% HigherWhat's Next? - MarketBeat
Eczema Clinical Trial Pipeline Accelerates as 100+ Pharma Companies Rigorously Develop Drugs for Market Entry | DelveInsight - The Manila Times
Corvus Pharmaceuticals Reports Promising Phase 1 Data for Soquelitinib in Relapsed/Refractory T Cell Lymphoma at ASH Annual Meeting - Quiver Quantitative
Corvus Pharmaceuticals Presents Final Data from Soquelitinib Phase 1/1b T Cell Lymphoma Trial - Yahoo Finance
Corvus Pharma (CRVS) Stock Analysis Report | Financials & Insights - Benzinga
Corvus Pharmaceuticals (NASDAQ:CRVS) Sets New 12-Month HighHere's What Happened - MarketBeat
You might want to take a look at Corvus Pharmaceuticals Inc (CRVS) now - setenews.com
Will Corvus Pharmaceuticals Inc. stock split again soonMarket Performance Report & Growth Focused Investment Plans - Newser
Corvus Pharmaceuticals, Inc. (NASDAQ:CRVS) Receives Average Rating of “Moderate Buy” from Analysts - Defense World
Corvus Pharmaceuticals (NASDAQ:CRVS) Stock Price Down 8%Here's What Happened - MarketBeat
Here's Why We're Not Too Worried About Corvus Pharmaceuticals' (NASDAQ:CRVS) Cash Burn Situation - Yahoo Finance
Is Corvus Pharmaceuticals Inc. stock a buy before product launchesDividend Hike & Intraday High Probability Alerts - Newser
Corvus Pharmaceuticals, Inc. (NASDAQ:CRVS) Receives Average Rating of "Moderate Buy" from Analysts - MarketBeat
Perhaps timely catching Corvus Pharmaceuticals Inc (CRVS) would be a good idea - Setenews
Foresite Capital Management VI LLC Boosts Position in Corvus Pharmaceuticals, Inc. $CRVS - MarketBeat
Corvus Pharmaceuticals: Trial Momentum Keeps Stock In Focus - RTTNews
What risks investors should watch in Corvus Pharmaceuticals Inc. stockWeekly Trend Summary & Weekly Watchlist for Consistent Profits - newser.com
Will Corvus Pharmaceuticals Inc. stock reach Wall Street targetsPortfolio Growth Summary & Technical Buy Zone Confirmation - newser.com
Is Corvus Pharmaceuticals Inc. stock affected by interest rate hikes2025 Geopolitical Influence & Consistent Profit Trading Strategies - newser.com
Is Corvus Pharmaceuticals Inc. stock supported by innovation pipeline2025 Analyst Calls & Consistent Profit Trading Strategies - newser.com
What valuation multiples suggest for Corvus Pharmaceuticals Inc. stockRecession Risk & AI Forecast Swing Trade Picks - newser.com
Corvus Pharmaceuticals Inc. stock momentum explainedWeekly Profit Report & Verified Swing Trading Watchlist - newser.com
Its Stock Has Paid Off Big Time For Corvus Pharmaceuticals Inc - Setenews
BML Capital Management LLC Buys New Stake in Corvus Pharmaceuticals, Inc. $CRVS - MarketBeat
Corvus Pharmaceuticals Inc. recovery potential after sell offPortfolio Update Summary & Safe Capital Growth Tips - newser.com
Using RSI to spot recovery in Corvus Pharmaceuticals Inc.Earnings Growth Report & Long-Term Growth Portfolio Plans - newser.com
Combining price and volume data for Corvus Pharmaceuticals Inc.July 2025 Decliners & Reliable Momentum Entry Alerts - newser.com
Is Corvus Pharmaceuticals Inc. forming a bottoming baseTrade Risk Summary & Fast Moving Stock Watchlists - newser.com
What drives Corvus Pharmaceuticals Inc stock priceEarnings Miss Alerts & Free Wealth Planning Blueprints - earlytimes.in
Published on: 2025-11-28 13:27:18 - earlytimes.in
What machine learning models say about Corvus Pharmaceuticals Inc.Weekly Profit Analysis & Reliable Breakout Stock Forecasts - newser.com
How to build a dashboard for Corvus Pharmaceuticals Inc. stockJuly 2025 Selloffs & Fast Momentum Stock Entry Tips - newser.com
Is Corvus Pharmaceuticals Inc. stock a defensive play in 2025July 2025 Recap & Long-Term Safe Investment Ideas - newser.com
Should you wait for a breakout in Corvus Pharmaceuticals Inc.Index Update & Safe Entry Zone Tips - newser.com
Corvus Pharmaceuticals Inc (CRVS) 財務データ
収益
当期純利益
現金流量
EPS
1.08%
0.91%
大文字化:
|
ボリューム (24 時間):